BioSeek to Evaluate Compounds for GSK
BioSeek this week said that it has entered into a collaboration with GlaxoSmithKline under which it will use its BioMAP Systems to characterize certain GSK compounds.
BioSeek's BioMAP Systems are a series of human primary cell-based assays designed to replicate human disease biology.
Financial terms of the agreement were not disclosed.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.